Rigel Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amgen USD 1.69B 191M 2025-03
Arrowhead Research USD 27.89M 2.3M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Celldex Therapeutics USD 10.82M 557K 2025-03
Daiichi Sankyo JPY 208.21B 22.58B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Veracyte USD 59.16M 8.45M 2025-03



Rigel Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.